{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Topical+vehicle+solution&page=4", "query": { "intervention": "Topical vehicle solution", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 137, "total_pages": 14, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Topical+vehicle+solution&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Topical+vehicle+solution&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T22:53:19.433Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01816529", "title": "Topical Safety Study of Topical Diltiazem Hydrochloride", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diltiazem Skin Sensitivity." ], "interventions": [ { "name": "Diltiazem Hydrochloride 2% Cream", "type": "DRUG" }, { "name": "Vehicle Cream", "type": "DRUG" }, { "name": "0.1% solution of sodium lauryl sulfate (SLS)", "type": "DRUG" }, { "name": "Saline (0.9%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ventrus Biosciences, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2013-03", "completion_date": "2013-09", "has_results": false, "last_update_posted_date": "2013-08-21", "last_synced_at": "2026-10-21T22:53:19.433Z", "location_count": 1, "location_summary": "Paramus, New Jersey", "locations": [ { "city": "Paramus", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01816529" }, { "nct_id": "NCT00847912", "title": "CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Carcinoma, Basal Cell", "Carcinoma, Squamous Cell", "Skin Neoplasms", "Skin Diseases", "Neoplasms, Basal Cell", "Neoplasms, Squamous Cell", "Carcinoma" ], "interventions": [ { "name": "5-fluorouracil", "type": "DRUG" }, { "name": "Placebo, vehicle control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 954, "start_date": "2009-06-26", "completion_date": "2016-07-30", "has_results": true, "last_update_posted_date": "2021-06-11", "last_synced_at": "2026-10-21T22:53:19.433Z", "location_count": 13, "location_summary": "Palo Alto, California • San Diego, California • Denver, Colorado + 10 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Bay Pines", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00847912" }, { "nct_id": "NCT01787448", "title": "RIPT of Ibuprofen Topical Gel", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Topical gel vehicle", "type": "DRUG" }, { "name": "Sodium lauryl sulfate 0.1%", "type": "DRUG" }, { "name": "Sodium chloride solution 0.9% (saline)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 234, "start_date": "2013-01", "completion_date": "2013-02", "has_results": false, "last_update_posted_date": "2013-02-28", "last_synced_at": "2026-10-21T22:53:19.433Z", "location_count": 1, "location_summary": "Carlstadt, New Jersey", "locations": [ { "city": "Carlstadt", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01787448" }, { "nct_id": "NCT06369675", "title": "Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Erythema" ], "interventions": [ { "name": "MOB015B", "type": "DRUG" }, { "name": "0.2% SLS", "type": "DRUG" }, { "name": "0.9% Saline", "type": "DRUG" }, { "name": "MOB015B vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Moberg Pharma AB", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2017-10-19", "completion_date": "2017-11-14", "has_results": false, "last_update_posted_date": "2024-04-17", "last_synced_at": "2026-10-21T22:53:19.433Z", "location_count": 1, "location_summary": "Fair Lawn, New Jersey", "locations": [ { "city": "Fair Lawn", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06369675" }, { "nct_id": "NCT01986920", "title": "Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Seborrheic Keratosis (SK)" ], "interventions": [ { "name": "A-101 25%", "type": "DRUG" }, { "name": "A-101 32.5%", "type": "DRUG" }, { "name": "A-101 40%", "type": "DRUG" }, { "name": "A-101 Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aclaris Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2013-10-22", "completion_date": "2014-02-25", "has_results": true, "last_update_posted_date": "2018-12-11", "last_synced_at": "2026-10-21T22:53:19.433Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01986920" }, { "nct_id": "NCT03024060", "title": "Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Actinic Keratosis" ], "interventions": [ { "name": "ALA", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" }, { "name": "IBL 20 mW", "type": "DEVICE" }, { "name": "IBL 10 mW", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "DUSA Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2017-03", "completion_date": "2018-01", "has_results": false, "last_update_posted_date": "2017-11-07", "last_synced_at": "2026-10-21T22:53:19.433Z", "location_count": 7, "location_summary": "San Diego, California • Arlington Heights, Illinois • Carmel, Indiana + 4 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Arlington Heights", "state": "Illinois" }, { "city": "Carmel", "state": "Indiana" }, { "city": "Plainfield", "state": "Indiana" }, { "city": "Fridley", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03024060" }, { "nct_id": "NCT04913519", "title": "A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alopecia, Androgenetic" ], "interventions": [ { "name": "TDM-105795", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Technoderma Medicines Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 30, "start_date": "2021-04-27", "completion_date": "2021-12-31", "has_results": false, "last_update_posted_date": "2022-04-27", "last_synced_at": "2026-10-21T22:53:19.433Z", "location_count": 2, "location_summary": "San Diego, California • College Station, Texas", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "College Station", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04913519" }, { "nct_id": "NCT03148691", "title": "A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Seborrheic Keratosis" ], "interventions": [ { "name": "A-101", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aclaris Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 253, "start_date": "2017-05-17", "completion_date": "2018-04-03", "has_results": true, "last_update_posted_date": "2019-05-06", "last_synced_at": "2026-10-21T22:53:19.433Z", "location_count": 9, "location_summary": "Washington D.C., District of Columbia • Miami, Florida • Newnan, Georgia + 6 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" }, { "city": "Newnan", "state": "Georgia" }, { "city": "New York", "state": "New York" }, { "city": "Fort Washington", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03148691" }, { "nct_id": "NCT02127463", "title": "Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Non-Exudative Age Related Macular Degeneration" ], "interventions": [ { "name": "MC-1101", "type": "DRUG" }, { "name": "MC-1101 Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MacuCLEAR, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 60, "start_date": "2014-04", "completion_date": "2016-04", "has_results": false, "last_update_posted_date": "2014-04-30", "last_synced_at": "2026-10-21T22:53:19.433Z", "location_count": 1, "location_summary": "Murray, Utah", "locations": [ { "city": "Murray", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02127463" }, { "nct_id": "NCT05360966", "title": "Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dry Eye Disease" ], "interventions": [ { "name": "0.003% AR-15512 ophthalmic solution", "type": "DRUG" }, { "name": "AR-15512 vehicle ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aerie Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 467, "start_date": "2022-07-18", "completion_date": "2023-10-17", "has_results": true, "last_update_posted_date": "2025-07-23", "last_synced_at": "2026-10-21T22:53:19.433Z", "location_count": 23, "location_summary": "Chico, California • Fullerton, California • Newport Beach, California + 20 more", "locations": [ { "city": "Chico", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05360966" } ] }